Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders

Joachim G.S. Veit, Valérie De Glas, Benoît Balau, Haoming Liu, Florence Bourlond, Amy S. Paller, Yves Poumay, Philippe Diaz

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Characterization of CYP26B1-Selective Inhibitor, DX314, as a Potential Therapeutic for Keratinization Disorders'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science